Paper Details

  1. Home
  2. Paper Details

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia.

Author: Ascher-SvanumHaya, CaseMichael G, SchuhKory J, WitteMichael M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Olanzapine long-acting injection (olanzapine-LAI) improved functioning in acutely ill patients with schizophrenia within 8 weeks of treatment initiation.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the effects of olanzapine long-acting injection (olanzapine-LAI) on levels of functioning in acutely ill patients with schizophrenia. RESEARCH DESIGN AND METHODS: During this 8-week randomized, double-blind, placebo-controlled trial, 404 inpatients were randomized to four treat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1185/03007995.2012.657300

データ提供：米国国立医学図書館（NLM）

Olanzapine Long-Acting Injection: A New Approach for Schizophrenia Treatment

Schizophrenia is a complex mental disorder that affects millions of people. This study investigated the effects of olanzapine long-acting injection (olanzapine-LAI) on levels of functioning in patients with schizophrenia. It's like a quest to find a better path for people navigating the challenging terrain of schizophrenia.

Improving Functioning in Schizophrenia

The study found that olanzapine-LAI improved levels of functioning in patients with schizophrenia, particularly in areas like social relationships and daily activities. It's like a compass guiding patients towards a more fulfilling life, despite the challenges of their condition.

The Promise of Long-Acting Medication

This research suggests that olanzapine-LAI could be a valuable treatment option for schizophrenia, offering benefits like improved functioning and potentially better adherence to medication. It's like a new bridge connecting patients with a better quality of life, one step at a time.

Dr.Camel's Conclusion

This study offers promising evidence for the effectiveness of olanzapine-LAI in improving functioning and quality of life for patients with schizophrenia. It highlights the potential of long-acting medications to provide sustained benefits and support long-term recovery.

Date :
  1. Date Completed 2012-08-20
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

22236137

DOI: Digital Object Identifier

10.1185/03007995.2012.657300

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.